Palexia Retard (Tapentadol Hydrochloride)

Tapentadol Hydrochloride, the active ingredient in Palexia Retard, is an opioid analgesic presented as a oral tablet for oral use. It is indicated for the management of moderate to severe chronic pain in adult patients when other treatments are inadequate. GNH USA supplies Palexia Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Palexia Retard is an opioid analgesic that is used primarily for chronic pain management in the following conditions:

- Chronic low back pain: Provides pain relief when conventional analgesics are insufficient. - Cancer‑related pain: Offers moderate to severe pain control for patients with malignant tumors. - Post‑operative post‑operative pain after major surgery : Helps to manage the intensive pain that occurs after the ...

Common ... 

...

...